Merck 4Q07 4Q Revenues: $6.2 billion (+3%) 4Q Loss: $1.6 billion (earnings were $473.9 million in 4Q06) FY Revenues: $24.2 billion (+7%) FY Earnings: $3.3 billion (-26%) Comments: 4Q Singulair sales were up 20% to $1.2 billion and FY sales were $4.3 billion (+19%). Global sales of Cozaar and Hyzaar were $891 million in the quarter (+ 3%) and were $3.4 billion for the year (+6%). Worldwide sales of Fosamax and Fosamax plus D were $796 million in the quarter (+1%) and for the year w...